News collected by Blogwritter News| India| 15’th August| 12:30 AM
Only one news is today there on social media -‘Bharat Biotech’s Covaxin is safe‘. Actually Bharat Biotech announced yesterday that they successfully competed first phase human trial of Covaxin. There this vaccine found safe.
Covaxin is a COVID-19 vaccine which is indigenously developed by Bharat Biotech . And yesterday they announced the phase one trial’s result. The data is yet to be published in public. Reports are coming from the centres in where this vaccine actually tested. And it’s showing the positive results without created any side effects.
Expert’s view :
As per the view of the in-charge of the trial of PGI Rohtak ,they have not observed any adverse effects in any volunteer.
Dr. Sanjay Rai from all India institute of Medical Sciences in Delhi claimed for the same . As per the Doctor they started trial in the middle of July . They enrolled 16 volunteers and all are safe without any side effects.
This Hyderabad based company is planning to start phase 2 trial from rSeptember. As per the report 375 participants tested this Covaxin’s first shot . And in phase 2 they are planning for 750 participants will be vaccinated.
Now we all are excited to see more positive responses from Covaxin. Let’s hope now that soon the data of phase 1 will be published.